Paired urine and plasma ctDNA profiling to enable longitudinal molecular monitoring during HER2 ADC bladder preserving therapy in muscle-invasive bladder cancer (HOPE03).
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Sichuan University, West China Hospital of Sichuan University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162689970
Cites:
Cited by:
Related to:
